CAPLIPOINT - Caplin Point Laboratories

Caplin Point Laboratories

CAPLIPOINT · Pharma > Pharmaceuticals & Drugs · Chairman: C C Paarthipan · MD: Sridhar Ganesan · Listing date: June 23, 2014 · Employees: 1675 · Chennai · http://www.caplinpoint.net

Stock Price vs Company Growth

2.9%

1.4%

12.3%

19.8%

1.6%

55.2%

50.8%

10y

27.6%

all

46.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 2,034 2.9%

1,632

2,600

Company Overview

Sales

1,888 Cr

Growth: 15.3%

Profit after Tax

515 Cr

Growth: 4.4%

Mid Cap

15,463 Cr

P/E: 30.1x

Industry P/E: 32.9x

Fundamentals

Sales (Cr)	₹ 1,888
Growth	15.3%
EBITDA	33.1%
P/S	8.2x
Dividend	0.3%
P/E	30.1x
Book Value	₹ 356
PEG Ratio	1.9x
ROE	20.5%
P/B	5.5x

Shareholding Pattern

Institutions

Promoters

P Vijayalakhsmi

23.64 %

Paarthipan C C

18.73 %

Ashok Gorkey Partheeban

11.96 %

Partheeban Vivek Siddarth

11.9 %

May India Property Private Limited

2.8 %

Others

Iepf

2.46 %

Visalatchi

2.22 %

Suresh Kumar Agarwal

1.32 %

Ashish Kacholia

1.16 %

Llp

0.7 %

Increase Decrease No change

Company Profile Detailed

Caplin Point is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Belongs to (21 Indices) view more

Investors (51)

matthewa...

ashish.k...

liabilit...

Followers (28)

rohit66

damerla

bhaskar2